Vanguard Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.34B | Buy |
13,297,139
+240,534
| +2% | +$78.4M | 0.07% | 277 |
|
2025
Q1 | $3.53B | Buy |
13,056,605
+323,206
| +3% | +$87.3M | 0.06% | 297 |
|
2024
Q4 | $3B | Buy |
12,733,399
+98,303
| +0.8% | +$23.1M | 0.05% | 348 |
|
2024
Q3 | $3.48B | Buy |
12,635,096
+127,318
| +1% | +$35M | 0.06% | 310 |
|
2024
Q2 | $3.04B | Buy |
12,507,778
+513,517
| +4% | +$125M | 0.06% | 322 |
|
2024
Q1 | $1.79B | Buy |
11,994,261
+50,366
| +0.4% | +$7.53M | 0.04% | 480 |
|
2023
Q4 | $2.29B | Buy |
11,943,895
+287,064
| +2% | +$54.9M | 0.05% | 381 |
|
2023
Q3 | $2.06B | Buy |
11,656,831
+30,608
| +0.3% | +$5.42M | 0.05% | 381 |
|
2023
Q2 | $2.21B | Buy |
11,626,223
+18,056
| +0.2% | +$3.43M | 0.05% | 385 |
|
2023
Q1 | $2.33B | Buy |
11,608,167
+101,051
| +0.9% | +$20.2M | 0.06% | 353 |
|
2022
Q4 | $2.73B | Buy |
11,507,116
+453,808
| +4% | +$108M | 0.07% | 295 |
|
2022
Q3 | $2.21B | Buy |
11,053,308
+10,870
| +0.1% | +$2.18M | 0.07% | 324 |
|
2022
Q2 | $1.61B | Buy |
11,042,438
+213,294
| +2% | +$31.1M | 0.05% | 432 |
|
2022
Q1 | $1.77B | Buy |
10,829,144
+126,373
| +1% | +$20.6M | 0.04% | 463 |
|
2021
Q4 | $1.81B | Buy |
10,702,771
+88,189
| +0.8% | +$15M | 0.04% | 465 |
|
2021
Q3 | $2B | Buy |
10,614,582
+116,888
| +1% | +$22.1M | 0.05% | 421 |
|
2021
Q2 | $1.78B | Sell |
10,497,694
-88,127
| -0.8% | -$14.9M | 0.04% | 462 |
|
2021
Q1 | $1.49B | Buy |
10,585,821
+59,397
| +0.6% | +$8.39M | 0.04% | 492 |
|
2020
Q4 | $1.37B | Sell |
10,526,424
-5,782
| -0.1% | -$751K | 0.04% | 481 |
|
2020
Q3 | $1.53B | Sell |
10,532,206
-368,978
| -3% | -$53.7M | 0.05% | 391 |
|
2020
Q2 | $1.61B | Buy |
10,901,184
+355,379
| +3% | +$52.6M | 0.06% | 355 |
|
2020
Q1 | $1.15B | Buy |
10,545,805
+258,333
| +3% | +$28.1M | 0.05% | 401 |
|
2019
Q4 | $1.18B | Buy |
10,287,472
+124,601
| +1% | +$14.4M | 0.04% | 492 |
|
2019
Q3 | $817M | Buy |
10,162,871
+846,185
| +9% | +$68.1M | 0.03% | 586 |
|
2019
Q2 | $676M | Buy |
9,316,686
+657,595
| +8% | +$47.7M | 0.03% | 666 |
|
2019
Q1 | $809M | Buy |
8,659,091
+439,757
| +5% | +$41.1M | 0.03% | 576 |
|
2018
Q4 | $599M | Buy |
8,219,334
+614,081
| +8% | +$44.8M | 0.03% | 629 |
|
2018
Q3 | $666M | Buy |
7,605,253
+66,740
| +0.9% | +$5.84M | 0.03% | 667 |
|
2018
Q2 | $742M | Buy |
7,538,513
+95,107
| +1% | +$9.37M | 0.03% | 600 |
|
2018
Q1 | $887M | Buy |
7,443,406
+179,492
| +2% | +$21.4M | 0.04% | 534 |
|
2017
Q4 | $923M | Buy |
7,263,914
+771,016
| +12% | +$98M | 0.04% | 520 |
|
2017
Q3 | $763M | Buy |
6,492,898
+73,390
| +1% | +$8.62M | 0.04% | 559 |
|
2017
Q2 | $512M | Buy |
6,419,508
+759,295
| +13% | +$60.6M | 0.03% | 692 |
|
2017
Q1 | $290M | Buy |
5,660,213
+200,890
| +4% | +$10.3M | 0.01% | 980 |
|
2016
Q4 | $204M | Buy |
5,459,323
+41,374
| +0.8% | +$1.55M | 0.01% | 1147 |
|
2016
Q3 | $367M | Buy |
5,417,949
+32,440
| +0.6% | +$2.2M | 0.02% | 768 |
|
2016
Q2 | $299M | Buy |
5,385,509
+182,614
| +4% | +$10.1M | 0.02% | 828 |
|
2016
Q1 | $327M | Buy |
5,202,895
+154,674
| +3% | +$9.71M | 0.02% | 758 |
|
2015
Q4 | $475M | Buy |
5,048,221
+416,709
| +9% | +$39.2M | 0.03% | 603 |
|
2015
Q3 | $372M | Buy |
4,631,512
+91,515
| +2% | +$7.35M | 0.03% | 682 |
|
2015
Q2 | $544M | Buy |
4,539,997
+212,011
| +5% | +$25.4M | 0.04% | 558 |
|
2015
Q1 | $452M | Buy |
4,327,986
+607,212
| +16% | +$63.4M | 0.03% | 631 |
|
2014
Q4 | $361M | Buy |
3,720,774
+137,474
| +4% | +$13.3M | 0.03% | 681 |
|
2014
Q3 | $280M | Buy |
3,583,300
+306,374
| +9% | +$23.9M | 0.02% | 773 |
|
2014
Q2 | $207M | Buy |
3,276,926
+595,350
| +22% | +$37.6M | 0.02% | 941 |
|
2014
Q1 | $180M | Sell |
2,681,576
-285,677
| -10% | -$19.2M | 0.02% | 981 |
|
2013
Q4 | $191M | Buy |
2,967,253
+130,410
| +5% | +$8.39M | 0.02% | 919 |
|
2013
Q3 | $182M | Buy |
2,836,843
+103,095
| +4% | +$6.6M | 0.02% | 896 |
|
2013
Q2 | $84.8M | Buy |
+2,733,748
| New | +$84.8M | 0.01% | 1279 |
|